Please login to the form below
Myalept
This page shows the latest Myalept news and features for those working in and with pharma, biotech and healthcare.
R&D productivity takes off
For example, Amgen's Blincyto (blinatumomab) for a rare form of leukaemia has been priced at $178, 000 a year, while AZ's Myalept (metreleptin) for the ultra-rare metabolic disorder
Latest news
-
Nexium windfall lifts AZ in third quarter
Meanwhile, AZ also said it is selling Myalept (metreleptin), an approved drug for generalised lipodystrophy, to Aegerion Pharmaceuticals. ... The latter will pay $325m upfront to acquire the global rights to Myalept, subject to an existing distributor
-
FDA approves AZ’s fish oil drug
Epanova gets green light to reduce high levels of fat in the blood
-
AZ gets limited approval for metreleptin in US
First FDA-backed treatment for rare disease lipodystrophy. AstraZeneca's Myalept has become the first approved treatment for the rare disease lipodystrophy after getting a green light from the FDA. ... Myalept will be "a much-needed treatment option for
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Featured jobs
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Account Director, Medical Education
-
Salary TBC
-
Senior External Communications Lead
-
£Competitive Salary
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Account Manager
-
£Competitive Salary
-
Experienced medical editor
-
Competitive salary and bonus scheme
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
-
Account Manager (PR)
-
Great Benefits
-
Publications director
-
Competitive salary and bonus scheme
-
Scientific Director
-
£60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Account Director, Healthcare Communications
-
Salary TBC
-
Account Director
-
£Competitive Salary
-
Account director
-
Competitive salary and bonus scheme
Subscribe to our email news alerts
- Merck’s Ebola vaccine wins approval in four African countries
- Genital herpes vaccine candidate heads for human studies
- BMS unveils long-term results for Opdivo in kidney cancer
- Categories - Communiqué Awards
- Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
- Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
- Introducing Nucleus POLAR™, a state-of-the-art external expert search engine and engagement management tool
- GSK pays $50m upfront to tap Immatics’ cell therapy platform
- Researchers discover new antibiotic using AI
- Bedrock Group celebrates a trio of new hires
- Tocagen merges with Forte Biosciences after brain cancer fail
- Immutep spikes on trial of its LAG-3 drug with Keytruda
PMHub
Fishawack Group of Companies
The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...
Latest intelligence
- Novo Nordisk awakens its ‘Sleeping Beauty’
- Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
- How will the Tories’ historic win shape the NHS?
- Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
- CSR 'Christmas Spirit' 2019
- OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...
Quick links
Infographics
